Evonik Industries (EVK) Given a €24.50 Price Target by JPMorgan Chase & Co. Analysts
JPMorgan Chase & Co. set a €24.50 ($28.49) price objective on Evonik Industries (FRA:EVK) in a report published on Thursday morning. The firm currently has a neutral rating on the stock.
Several other equities research analysts also recently commented on the company. Sanford C. Bernstein set a €37.00 ($43.02) target price on Evonik Industries and gave the company a buy rating in a report on Friday, September 14th. UBS Group set a €29.00 ($33.72) target price on shares of Evonik Industries and gave the company a sell rating in a research note on Monday, September 17th. Commerzbank set a €39.00 ($45.35) target price on shares of Evonik Industries and gave the company a buy rating in a research note on Monday, September 17th. Deutsche Bank set a €40.00 ($46.51) target price on shares of Evonik Industries and gave the company a buy rating in a research note on Monday, September 17th. Finally, Societe Generale set a €40.00 ($46.51) target price on shares of Evonik Industries and gave the company a buy rating in a research note on Monday, September 17th. Five equities research analysts have rated the stock with a sell rating, six have issued a hold rating and twelve have given a buy rating to the stock. The company presently has a consensus rating of Hold and an average target price of €31.55 ($36.68).
Shares of EVK stock traded down €0.37 ($0.43) during mid-day trading on Thursday, reaching €23.11 ($26.87). The stock had a trading volume of 950,476 shares. Evonik Industries has a 12-month low of €26.78 ($31.14) and a 12-month high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
See Also: Treasury Bonds
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.